CONTROVERSY: DCGI exempts Biocon from Phase 3 trial of COVID drug Itolizumab, ICMR sees red Farhat Nasim17 July 2020 4:21 PM ISTBengaluru: In a major controversy, the exemption of biotechnology major Biocon from conducting Phase 3 trials of its psoriasis drug...
Biocon Chief condemns ICMR for not permitting Asymptomatic Testing Ruchika Sharma27 Jun 2020 11:55 AM ISTBengaluru: Biotechnology industry veteran Kiran Mazumdar-Shaw on Friday criticised the Indian Council of Medical Research for "not permitting"...
Biocon Chief Kiran Shaw wins EY World Entrepreneur of the Year 2020 Award Ruchika Sharma7 Jun 2020 10:45 AM ISTIn the award's 20-year history, Mazumdar-Shaw is the first woman entrepreneur from India and the third Indian to win it
Stimulus package can help biotech sector become self-reliant: Kiran Mazumdar-Shaw Ruchika Sharma19 May 2020 9:00 AM ISTNew Delhi: Biocon Executive Chairperson Kiran Mazumdar-Shaw on Saturday pitched for a stimulus package for the biotechnology sector with a view to...
Biocon net down 42% quarterly, 17% yearly MD Bureau15 May 2020 8:45 PM ISTBengaluru, May 15 (IANS) Leading biotechnology firm Biocon reported Rs 123 crore consolidated net profit for the fourth quarter (Q4) of fiscal...
COVID-19 Testing Kits: Mylab joins hands with Syngene International Ruchika Sharma27 April 2020 1:16 PM ISTPune: In a major step to make India self-reliant in COVID-19 testing, Mylab Discovery Solutions, a Pune based molecular diagnostics has collaborated...
COVID-19 will reboot world into virtual reality: Kiran Mazumdar-Shaw Ruchika Sharma20 April 2020 12:32 PM ISTNew Delhi: COVID-19 will reboot the world into virtual reality and after the crisis, work from home models are likely to continue and business travel...
Medical Council of India Unethical, Corrupt : Kiran Mazumdar Shaw savita thakur thakur29 March 2017 11:24 AM ISTIn a recent interview with daily ZoomTV, Kiran Mazumdar Shaw, the chairman and managing director of Biocon Limited, was seen slamming Medical Council...
Need $5 billion more to make biotech a $100 billion sector: Kiran Mazumdar-Shaw savita thakur thakur11 Feb 2016 8:18 AM ISTBENGALURU: Biocon chief Kiran Mazumdar Shaw said it will take an investment worth $5 billion in biotechnology to realise the target of making it a...
Biocon amongst the top Biopharma companies in a global survey Pooja Bhatia Bhatia4 Nov 2015 10:33 AM ISTBiocon Ltd, in a recent press report, has stated its achievement of earning the reputation and distinction of being the only Asian Biopharma company...
Biocon targets emerging, developed markets with biosimilars Meghna A Singhania23 Oct 2015 8:38 AM ISTNEW DELHI: Biopharmaceuticals firm Biocon is looking to tap opportunities in biosimilars targeting diseases such as diabetes and cancer among others,...
New manufacturing unit for Biocon in Bengaluru Pooja Bhatia Bhatia16 Sept 2015 11:02 AM ISTBiocon has launched its new manufacturing facility in Bengaluru to provide pen-like insulin devices for diabetes patients. It aims to strengthen the...
